Oric Pharmaceuticals (ORIC) Non-Current Deferred Tax Liability (2022 - 2025)
Oric Pharmaceuticals' (ORIC) quarterly Non-Current Deferred Tax Liability came in at $220000.0 in Q4 2025, down 91.5% YoY from $2.6 million in Q4 2024, and down 91.5% on a QoQ basis from $2.6 million in Q4 2024.
Oric Pharmaceuticals (ORIC) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $220000.0 in Q4 2025.
- Quarterly Non-Current Deferred Tax Liability fell 91.5% year-over-year to $220000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $220000.0 (down 91.5% YoY) and the FY2025 annual result came in at $220000.0, down 91.5% from the prior year.
- Non-Current Deferred Tax Liability retreated to $220000.0 in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $24.0 million in Q4 2023 to a low of $106000.0 in Q4 2022.
- A 4-year average of $6.7 million and a median of $1.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability surged 22567.92% — and 2025, when it sank 91.5%.
- Tracing ORIC's Non-Current Deferred Tax Liability over 4 years: stood at $106000.0 in 2022, then surged by 22567.92% to $24.0 million in 2023, then tumbled by 89.23% to $2.6 million in 2024, then slumped by 91.5% to $220000.0 in 2025.
- The last three Non-Current Deferred Tax Liability figures came in at $220000.0 (Q4 2025), $2.6 million (Q4 2024), and $24.0 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2025 | 220,000.00 |
| Dec 31, 2024 | 2.59 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 24.03 Mn |
| Dec 31, 2023 | 24.03 Mn |
| Dec 31, 2022 | 106,000.00 |
| Dec 31, 2022 | 106,000.00 |